House Bill Would Remove Home Oxygen from Medicare Bidding, Boost Supplier Payments
The SOAR Act of 2025 is currently sitting in the House Energy and Commerce and Ways and Means committees. No action has been taken on this bill since April 2025, and it is considered stalled. The bill must be reviewed by these committees before it can move forward.
No action since April 2025
This bill’s path across every version that has carried it.
Reintroduced
Reintroduced from H.R. 7829 (118th), which died when its Congress ended.
H.R. 7829 (118th) →How this policy affects specific groups of people
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
The Supplemental Oxygen Access Reform (SOAR) Act has been reintroduced to remove oxygen from Medicare's competitive bidding program. The bill aims to establish separate payment rates for liquid and non-liquid oxygen and create an add-on payment for respiratory therapy services.
The SOAR Act is built on four pillars: making supplemental oxygen more patient-centric, addressing liquid oxygen access for high-flow patients, recognizing respiratory therapy services, and implementing standardized electronic templates to protect against fraud.
The SOAR Act would remove oxygen equipment from Medicare competitive bidding and establish a separate payment rate for liquid oxygen. Experts argue the current system creates 'needless suffering' by providing bulky equipment that limits patient mobility.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
SOAR Act of 2025
Analysis generated by AI. Always verify with official sources.